£19.4M
The Series B round was led by Leaps by Bayer to support clinical studies and technology development.
Medopad develops digital health platforms and remote patient monitoring tools to advance proactive medicine.
Medopad is a London-based health technology company that builds digital health platforms and remote patient monitoring tools for clinical research and care. It partners with healthcare systems and life science organisations to advance proactive medicine.
The Series B round was led by Leaps by Bayer to support clinical studies and technology development.